The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Self-citationIntegrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Self-citationThe role of angiogenesis in tumor growth.
Folkman, J. (1992) · PubMed · Cited by 1,259
Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.
Brooks, P. C., Strömblad, S., Klemke, R., Visscher, D., Sarkar, F. H., & Cheresh, D. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118227 · Cited by 828
Self-citationHorak, E. R., Klenk, N., Leek, R., LeJeune, S., Smith, K., Stuart, N., Harris, A. L., Greenall, M., & Stepniewska, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)93150-l · Cited by 800
Allen, T. M., Hansen, C., & Rutledge, J. (1989) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(89)90078-3 · Cited by 466
Meitar, D., Crawford, S. E., Rademaker, A. W., & Cohn, S. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.405 · Cited by 342
Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma
Takebayashi, Y., Akiyama, S.-I., Yamada, K., Akiba, S., & Aikou, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2<226::aid-cncr6>3.0.co;2-j · Cited by 225
Cited by
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Self-citationWeissleder, R., & Mahmood, U. (2001) · Radiology · doi:10.1148/radiology.219.2.r01ma19316 · Cited by 1,315
Integrins in angiogenesis and lymphangiogenesis
Avraamides, C. J., Garmy-Susini, B., & Varner, J. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2353 · Cited by 1,050
Imaging of angiogenesis: from microscope to clinic
McDonald, D. M., & Choyke, P. L. (2003) · Nature Medicine · doi:10.1038/nm0603-713 · Cited by 1,016
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Danhier, F., Le Breton, A., & Préat, V. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 955
Biomedical Applications of Graphene
Shen, H., Zhang, L., Liu, M., & Zhang, Z. (2012) · Theranostics · doi:10.7150/thno.3642 · Cited by 930
Applications of gold nanoparticles in cancer nanotechnology
Cai, W. (2008) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s3788 · Cited by 851
Griffioen, A. W., & Molema, G. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01448-0 · Cited by 842
Targeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Molecular imaging in drug discovery and development
Rudin, M., & Weissleder, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1007 · Cited by 815
Scaling down imaging: molecular mapping of cancer in mice
Weissleder, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc701 · Cited by 708
Eliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
Self-citationLiu, Y., Miyoshi, H., & Nakamura, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22709 · Cited by 620
Neri, D., & Bicknell, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1627 · Cited by 600
Classification and basic properties of contrast agents for magnetic resonance imaging
Geraldes, C. F. G. C., & Laurent, S. (2009) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.265 · Cited by 541
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Multimodality Molecular Imaging of Tumor Angiogenesis
Cai, W., & Chen, X. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045922 · Cited by 494
Haubner, R., Weber, W. A., Beer, A. J., Vabuliene, E., Reim, D., Sarbia, M., Becker, K.-F., Goebel, M., Hein, R., Wester, H.-J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020070 · Cited by 489
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Self-citationImaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to α v β 3
Ellegala, D. B., Leong-Poi, H., Carpenter, J. E., Klibanov, A. L., Kaul, S., Shaffrey, M. E., Sklenar, J., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000080326.15367.0c · Cited by 454
Nano-sized MRI contrast agents with dendrimer cores
KOBAYASHI, H., & BRECHBIEL, M. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.016 · Cited by 437
Gadolinium‐based contrast agents for magnetic resonance cancer imaging
Zhou, Z., & Lu, Z. (2013) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1198 · Cited by 427
The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Feng, L., Dong, Z., Tao, D., Zhang, Y., & Liu, Z. (2018) · National Science Review · doi:10.1093/nsr/nwx062 · Cited by 426
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Integrin and Growth Factor Receptor Crosstalk
Eliceiri, B. P. (2001) · Circulation Research · doi:10.1161/hh2401.101084 · Cited by 395
Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235724.11299.76 · Cited by 379
Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y., & Lu, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.020 · Cited by 366
Li, M.-L., Oh, J.-T., Xie, X., Ku, G., Wang, W., Li, C., Lungu, G., Stoica, G., & Wang, L. V. (2008) · Proceedings of the IEEE · doi:10.1109/jproc.2007.913515 · Cited by 352
Artemov, D., Mori, N., Okollie, B., & Bhujwalla, Z. M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10406 · Cited by 351
Gd(III)-BASED CONTRAST AGENTS FOR MRI
AIME, S., BOTTA, M., & TERRENO, E. (2005) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(05)57004-1 · Cited by 345
Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to α v -Integrins
Leong-Poi, H., Christiansen, J., Klibanov, A. L., Kaul, S., & Lindner, J. R. (2003) · Circulation · doi:10.1161/01.cir.0000044916.05919.8b · Cited by 334
Fibronectin and Its Integrin Receptors in Cancer
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60772-1 · Cited by 330
Iron oxide nanoparticles for targeted cancer imaging and diagnostics
Rosen, J. E., Chan, L., Shieh, D.-B., & Gu, F. X. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.08.017 · Cited by 329
Nanocrystal Core High-Density Lipoproteins: A Multimodality Contrast Agent Platform
Cormode, D. P., Skajaa, T., van Schooneveld, M. M., Koole, R., Jarzyna, P., Lobatto, M. E., Calcagno, C., Barazza, A., Gordon, R. E., Zanzonico, P., et al. (2008) · Nano Letters · doi:10.1021/nl801958b · Cited by 328
How to determine free Gd and free ligand in solution of Gd chelates. A technical note
Barge, A., Cravotto, G., Gianolio, E., & Fedeli, F. (2006) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.110 · Cited by 291
Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery
Lee, M., & Kim, S. W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9003-5 · Cited by 277
Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles
Anderson, S. A., Rader, R. K., Westlin, W. F., Null, C., Jackson, D., Lanza, G. M., Wickline, S. A., & Kotyk, J. J. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200009)44:3<433::aid-mrm14>3.0.co;2-9 · Cited by 271
Barrett, T., Brechbiel, M., Bernardo, M., & Choyke, P. L. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20991 · Cited by 266
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction
Meoli, D. F., Sadeghi, M. M., Krassilnikova, S., Bourke, B. N., Giordano, F. J., Dione, D. P., Su, H., Edwards, D. S., Liu, S., Harris, T. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420352 · Cited by 262
Molecular imaging of the tumor microenvironment
Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253
Targeting tumor vasculature with homing peptides from phage display
Ruoslahti, E. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0334 · Cited by 157
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
Kang, S., Lee, S., & Park, S. (2020) · Polymers · doi:10.3390/polym12091906 · Cited by 139
In Vivo mouse imaging and spectroscopy in drug discovery
Beckmann, N., Kneuer, R., Gremlich, H., Karmouty‐Quintana, H., Blé, F., & Müller, M. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1153 · Cited by 118
Molecular Theranostics: A Primer for the Imaging Professional
Lee, D. Y., & Li, K. C. P. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.6797 · Cited by 95
Self-citationFederman, N., Chan, J., Nagy, J. O., Landaw, E. M., McCabe, K., Wu, A. M., Triche, T., Kang, H., Liu, B., Marks, J. D., et al. (2012) · Sarcoma · doi:10.1155/2012/126906 · Cited by 44
Metadata
- Authors
- Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., & Li, K. C. P.
- Venue
- Nature Medicine
- Published
- 1998-05
- Volume
- 4
- Issue
- 5
- Pages
- 623-626
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1990036692
- Cited by
- 850
- References
- 15
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.